Compare InMode Ltd (INMD) vs Novartis AG (NVS) Price & Performance

InMode LtdTrade

Novartis AGTrade

Price performance (Past 24H)

Key statistics

InMode Ltd vs Novartis AG — how do they compare? InMode Ltd trades at $15.38 (market cap $882.90M), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 328.7× InMode Ltd's market cap, and Novartis AG pays a 3.17% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.

	INMD	NVS
Market Cap	$882.90M	$290.25B
Sector	Technology	Health
52-Week High	$16.62	$168.62
52-Week Low	$12.76	$113.50
Enterprise Value	$350.57M	$330.27B
Dividend Yield	—	3.17%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INMD

View details →

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 23 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

About InMode Ltd

InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.